Compare AbCellera Biologics Inc (ABCL) vs F5 Inc (FFIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs F5 Inc — how do they compare? AbCellera Biologics Inc trades at $9.21 (market cap $2.99B), while F5 Inc trades at $414 (market cap $23.44B). The key difference: F5 Inc is far larger — about 7.8× AbCellera Biologics Inc's market cap. Which is the better fit depends on your goals.
| ABCL | FFIV | |
|---|---|---|
Market Cap | $2.99B | $23.44B |
Sector | Health | Technology |
52-Week High | $9.76 | $431.26 |
52-Week Low | $2.78 | $223.99 |
Enterprise Value | $2.58B | $22.08B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About F5 Inc
F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.
Read more on FFIV →
